Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers

NCT02046083 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Peanut Allergy

Interventions

DRUG: arachid

Sponsor

University Hospital, Clermont-Ferrand